Dr Lucy Doos

Dr Lucy Doos

Institute of Applied Health Research
Senior Trial Manager

Contact details

Birmingham Clinical Trials Unit
Public Health Building
Institute of Applied Health Research
University of Birmingham
Birmingham, B15 2TT

Dr Lucy Doos is a senior trial manager at Birmingham Clinical Trials Unit.

ResearchGate profile


  • PhD in Health Service Management
  • MSc in Public Health and Epidemiology
  • MBBCh 


Dr Lucy Doos joined the Birmingham Clinical Trials Unit (BCTU) in 2022 and currently manages a number of trials in the areas of Women’s health and COPD. Prior to moving to BCTU, Lucy worked at Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, managing a number of trials related to breast cancer.

Formerly Lucy worked as a Research Fellow in the University of Birmingham leading on research related to public health and health technology assessment. Lucy has extensive experiences in medical research. She is a medical doctor with a Master’s degree in Public Health and Epidemiology and a PhD degree in Health Services Management (University of Birmingham, UK).

Lucy also worked in a number of British and overseas universities. She had international experiences as a medical doctor and a researcher overseas and worked with a number of international organisations such as the WHO and UNICEF.


Lucy currently teaches:

  •  First and second year Medical students
  • Third year pharmacy students

Postgraduate supervision

Lucy supervises PhD students:

  • Health education and female genital mutilation/cutting (FGM/C): A mixed methods inquiry about prevention in Birmingham, United Kingdom (Susan Waigwa).
  • Understanding the factors that perpetuate maternal health morbidities in Sub-Saharan Africa: Applying the three phase delay model as a framework for the case of obstetric fistula in Zambia (Eniya Lufumpa).


Research interests: Public Health, Clinical Trials, Health Service Management, Immigrants’ Health

 Current projects:


Dennis C. Sgroi*, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen J. Taylor, Elena Brachtel, Sarah Pirrie, Catherine A. Schnabel, Daniel Rea and John M. S. Bartlett. Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans‑aTTom study. Breast Cancer Research. 2022) 24:90 https://doi.org/10.1186/s13058-022-01589-x

John M. S. Bartlett, Dennis C. Sgroi,Kai Treuner, Yi Zhang, Tammy Piper, Ranelle C. Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen J. Taylor, Elena F. Brachtel, Sarah J. Pirrie, Catherine A. Schnabel,Daniel W. Rea. Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study. Clin Cancer Res clincanres.3385.2021. https://doi.org/10.1158/1078-0432.CCR-21-3385

Ian Litchfeld, Kate Marsden, Lucy Doos, Katherine Perryman, Anthony Avery and Sheila Greenfeld. A comparative assessment of two tools designed to support patient safety culture in UK general practice. BMC Fam Pract (2021) 22:98. https://doi.org/10.1186/s12875-021- 01438-4

Florence Samkange-Zeeb, Silja Samerski, Lucy Doos, Rachel Humphris, Beatriz Padilla and Hannah Bradby. “It's the First Barrier” – Lack of Common Language a Major Obstacle When Accessing/Providing Healthcare Services Across Europe. Front. Sociol., 05 November 2020, https://doi.org/10.3389/fsoc.2020.557563

Jenny Phillimore, Hannah Bradby, Lucy Doos, Beatriz Padilla, Silja Samerski. Health providers as bricoleurs: An examination of the adaption of health ecosystems to superdiversity in Europe. Journal of European Social Policy 2019, Vol. 29(3) 361–375.

Derek J Ward, Lucy Doos, Andrew Stevens. Trends in the costs of drugs launched in the UK between 1981 and 2015: an analysis of the launch price of drugs in five disease areas. BMJ Open 2019;9:e027625. doi:10.1136/bmjopen-2018-027625

Susan Waigwa, Lucy Doos, Caroline Bradbury-Jones, Julie Taylor. Effectiveness of health education as an intervention designed to prevent female genital mutilation/cutting (FGM/C): A systematic review. Reproductive Health; 2018; volume 15(1). DOI· 10.1186/s12978-018- 0503-x

Eniya Lufumpa, Lucy Doos and Antje Lindenmeyer. Barriers and facilitators to preventiveinterventions for the development of obstetric fistulas among women in sub- Saharan Africa: a systematic review. BMC Pregnancy and Childbirth (2018) 18:155. https://doi.org/10.1186/s12884-018-1787-0

Doos L, Packer C, Ward D, Simpson S, Stevens A. Past speculations of future health technologies: a description of technologies predicted in 15 forecasting studies 1986-2010. BMJ Open; 2017;7:e016206. doi:10.1136/bmjopen-2017-016206

Ojas Pujji, Nikita Keswani, Naomi Collier, Marion Black, Lucy Doos. Evaluating the functional results and complications of autograft vs allograft use for reconstruction of the anterior cruciate ligament: a systematic review. Orthopedic Reviews; 2017; volume 9:6833.

Doos L, Ward D, Stevens A, Packer C. Accuracy of pharmaceutical company licensing predictions: projected versus actual licensing dates. Journal of Pharmaceutical Health Services Research; 2016, 7; 117–122

Doos L, Packer C, Ward D, Simpson S, Stevens A. Past speculations of the future: a review of the methods used for forecasting emerging health technologies. BMJ Open; 2016;6:e010479. doi:10.1136/bmjopen-2015-010479.

Brugha TS, Doos L, Tempier A, Einfeld S, Howlin P Outcome measures in intervention trials for adults with autism spectrum disorders; a systematic review of assessments of core autism features and associated emotional and behavioural problems. International Journal of Methods in Psychiatric Research. Volume 24, Issue 2, pages 99–115, June 2015.

Patient Safety Toolkit for General Practice. Royal College of General Practitioners. http://www.rcgp.org.uk/clinical-and-research/toolkits/patient-safety.aspx

Lucy Doos, Eyitope O Roberts, Nadia Corp, Umesh T Kadam. Multi-drug therapy in chronic condition multimorbidity: A systematic review. Family Practice (2014) 31 (6): 654-663 first published online September 5, 2014 doi:10.1093/fampra/cmu056

Nderitu P, Doos L, Strauss V, Lambie M, Davies SJ, Kadam UT. Analgesia dose prescribing and chronic kidney disease progression: a general practice database linkage cohort study. BMJ Open; 2014;4:e005581. doi:10.1136/bmjopen-2014- 005581

Lucy Doos, Eleanor Bradley, Claire A Rushton, Duwarakan Satchithananda, Simon J Davies, Umesh T Kadam: Heart failure and COPD multimorbidity at hospital discharge transition: a study of patient and carer experience. Health Expectations 2014 May 16. doi: 10.1111/hex.12208. [Epub ahead of print].

Doos L, Jones PW, Kadam UT: Consumer Mosaic segmentation, COPD and CHF multimorbidity and hospital costs: a clinical linkage study in England. J Public Health (Oxf); 2014 Jun;36(2):317-24. doi: 10.1093/pubmed/fdt070. Epub 2013 Jul 30.

Paul Nderitu, Lucy Doos, Peter W Jones, Simon J Davies, Umesh T Kadam (2013): Non- steroidal anti-inflammatory drugs and chronic kidney disease progression: A systematic review. Family Practice; 2013 Jun;30(3):247-55. doi: 10.1093/fampra/cms086. Epub 2013 Jan 8

View all publications in research portal